Related content

Updates in Systemic Treatment for Metastatic Cervical Cancer

By Chao Angel   Lin Cheng-Tao   Lai Chyong-Huey  

Current Treatment Options in Oncology, Vol. 15, Iss. 1, 2014-03 ,pp. : 1-13

Springer Publishing Company

Access to resources Recommend Favorite

Vincristine, cisplatin, teniposide, and cyclophosphamide combination in the treatment of recurrent or metastatic adrenocortical cancer

By Khan Tanweera   Sundin Anders   Juhlin Claes   Wilander Erik   Öberg Kjell   Eriksson Barbro  

Medical Oncology, Vol. 21, Iss. 2, 2004-06 ,pp. : 167-177

Humana Press, Inc

Access to resources Recommend Favorite

Phase II clinical study of irinotecan and cisplatin as first-line chemotherapy in metastatic or recurrent cervical cancer

By Chitapanarux I.   Tonusin A.   Sukthomya V.   Charuchinda C.   Pukanhapan N.   Lorvidhaya V.  

Gynecologic Oncology, Vol. 89, Iss. 3, 2003-06 ,pp. : 402-407

Elsevier

Access to resources Recommend Favorite

New drugs for the treatment of metastatic or refractory soft tissue sarcomas in children

By Gupta Abha A   Pappo Alberto S  

Future Oncology, Vol. 2, Iss. 5, 2006-10 ,pp. : 675-685

Future Medicine

Access to resources Recommend Favorite

New targets, drugs, and approaches for the treatment of cancer: An overview

By Kerbel R.S.  

Cancer and Metastasis Reviews, Vol. 17, Iss. 2, 1998-06 ,pp. : 145-147

Springer Publishing Company

Access to resources Recommend Favorite